
Gastroenterologist

No OPD information available
Colitis
Crohn's Disease
Hemorrhagic Proctocolitis
Ulcerative Colitis
Viral Gastroenteritis
Necrosis
Chronic Pain
Colonoscopy
Cytomegalic Inclusion Disease
Endoscopy
Gastrointestinal Fistula
Irritable Bowel Syndrome (IBS)
Daniel R. Van Langenberg is a male healthcare provider who helps patients with various digestive problems like colitis, Crohn's Disease, and irritable bowel syndrome. He also performs procedures like colonoscopies and endoscopies to diagnose and treat these conditions. Daniel R. Van Langenberg is skilled in managing chronic pain and treating gastrointestinal issues.
Patients trust Daniel R. Van Langenberg because he communicates well with them, explaining their conditions and treatment options in a clear and caring manner. He listens to their concerns and works with them to develop personalized care plans. Patients appreciate his compassionate approach to healthcare.
To stay updated with the latest medical knowledge, Daniel R. Van Langenberg regularly reads research articles and attends conferences. He values learning and applies new information to improve patient care. By staying informed, he can offer the most effective treatments based on current medical evidence.
Daniel R. Van Langenberg collaborates with colleagues and other medical professionals to provide comprehensive care to patients. He values teamwork and respects the expertise of others in the healthcare field. By working together, they can offer patients the best possible outcomes.
Through his work, Daniel R. Van Langenberg has positively impacted many patients' lives by relieving their symptoms and improving their quality of life. His dedication to patient care and commitment to staying informed have led to successful treatment outcomes for many individuals.
One of Daniel R. Van Langenberg's notable publications discusses the use of a biosimilar in treating patients with inflammatory bowel disease. He has also conducted clinical trials to assess the efficacy and safety of a combination treatment for Crohn's Disease. These research efforts demonstrate his commitment to advancing medical knowledge and improving patient care.
Enrollment Status: Completed
Published: December 08, 2020
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
